Market Research Logo

Controlled Release Drug Delivery Market Analysis Report By Technology (Transdermal, Microencapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2018 - 2025

Controlled Release Drug Delivery Market Analysis Report By Technology (Transdermal, Microencapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2018 - 2025

The global controlled release drug delivery market size is expected to reach USD 90.18 billion by 2025, according to a new report by Grand View Research, Inc., registering a 13.8% CAGR during the forecast period. Some of the key factors accelerating market growth are need for alternative therapies, need for these systems for geriatric and pediatric use, and benefits offered by these technologies over conventional forms of drug delivery.

Controlled release drug delivery technologies offer various benefits over traditional medication delivery methods. Reduced dosage, lower dosage frequency, fewer adverse gastrointestinal effects, enhanced patient compliance, uniform drug effect, improved efficacy and safety of medication, and reduction in fluctuation of plasma drug levels are some of the benefits offered by these technologies. With an increase in R&D by various pharmaceutical companies, there has been a rise in adoption of these systems.

The North American region accounted for the largest market revenue share due to technologically advanced infrastructure, increasing R&D, and presence of major players and pharmaceutical companies in the region. The Asia Pacific region is anticipated to register the highest CAGR during the forecast period. Emerging countries such as China and India are expected to witness strong growth through 2025 owing to adoption of enhanced healthcare infrastructure and medical technologies for specialized patient care.

Further key findings from the study suggest:

  • Oral controlled release drug delivery systems held the largest market share owing to increase in usage and ease of convenience offered for administration of medication
  • Targeted drug delivery is anticipated to exhibit the highest CAGR during the forecast period owing to its various benefits and increasing adoption
  • Osmotic drug delivery is expected to emerge as the fastest growing segment due to its ability to not be affected by various factors such as pH, food consumption, and gastrointestinal motility
  • The North American region held the largest revenue share due to local presence of major market players and increasing R&D in the field to cater to rising number of patients
  • The Asia Pacific region is expected to showcase the highest CAGR during the forecast period owing to rising investments by dominant players in the region and developments in the pharmaceutical industry in emerging countries such as India and China.


Chapter 1 Research Methodology
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region-Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Controlled Release Drug Delivery Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Necessity of pediatric and geriatric controlled release dosage forms
3.2.2 Increased acceptance due to nature of dosage forms
3.3 Market Restraint Analysis
3.3.1 Limited amount of controlled release dosage forms is acceptable for usage in pediatric conditions
3.3.2 Need for high dose of Active Pharmaceutical Ingredient
3.3.3 Expensive nature of controlled-release systems in comparison to conventional pharmaceutical formulations
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by technology
3.4.2 Chapter 3 Controlled Release Drug Delivery Market – SWOT Analysis, By Factor (political & legal, economic and technological)
3.5 Industry Analysis – Porter’s
3.6 Controlled Relase Drug Delivery Market: Market Position Analysis
Chapter 4 Controlled Release Drug Delivery Market: Technology Estimates & Trend Analysis
4.1 Controlled Release Drug Delivery Market: Technology Movement Analysis
4.2 Wurster Technique
4.2.1 Wurster Technique market, 2014 - 2025 (USD Billion)
4.3 Coacervation
4.3.1 Coacervation market, 2014 - 2025 (USD Billion)
4.4 Micro Encapsulation
4.4.1 Micro encapsulation market, 2014 - 2025 (USD Billion)
4.5 Implants
4.5.1 Implants market, 2014 - 2025 (USD Billion)
4.6 Transdermal
4.6.1 Transdermal market, 2014 - 2025 (USD Billion)
4.7 Targeted Delivery
4.7.1 Targeted delivery market, 2014 - 2025 (USD Billion)
4.8 Others
4.8.1 Others market, 2014 - 2025 (USD Billion)
Chapter 5 Controlled Release Drug Delivery Market: Release Mechanism Estimates & Trend Analysis
5.1 Controlled Release Drug Delivery Market: Release Mechanism Movement Analysis
5.2 Polymer Based Drug Delivery Systems
5.2.1 Polymer based drug delivery systems market, 2014 - 2025 (USD Billion)
5.3 Micro Reservoir Partition Controlled Drug Delivery Systems
5.3.1 Micro reservoir partition controlled drug delivery market, 2014 - 2025 (USD Billion)
5.4 Feedback Regulated Drug Delivery Systems
5.4.1 Feedback regulated drug delivery systems market, 2014 - 2025 (USD Billion
5.5 Activation Modulated Drug Delivery Systems
5.5.1 Activation modulated drug delivery market, 2014 - 2025 (USD Billion)
5.6 Chemically Controlled Drug Delivery Systems
5.6.1 Chemically controlled drug delivery market, 2014 - 2025 (USD Billion)
Chapter 6 Controlled Release Drug Delivery Market: Application Estimates & Trend Analysis
6.1 Controlled Release Drug Delivery Market: Application Movement Analysis
6.2 Metered Dose Inhalers
6.2.1 Metered dose inhalers market, 2014 - 2025 (USD Billion)
6.3 Injectables
6.3.1 Injectables market, 2014 - 2025 (USD Billion)
6.4 Transdermal and Ocular Patches
6.4.1 Transdermal and Ocular Patches market, 2014 - 2025 (USD Billion)
6.5 Infusion Pumps
6.5.1 Infusion pumps market, 2014 - 2025 (USD Billion)
6.6 Oral controlled drug delivery
6.6.1 Oral controlled drug delivery market, 2014 - 2025 (USD Billion)
6.7 Drug Eluting Stents
6.7.1 Drug Eluting Stents market, 2014 - 2025 (USD Billion)
Chapter 7 Controlled Release Drug Delivery Market: Regional Estimates & Trend Analysis, by Technology, Release Mechanism, Application
7.1 Controlled Release Drug Delivery Market Share by Region, 2016 & 2025
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Depomed, Inc.
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 Coating Place, Inc.
8.1.2.1 Company Overview
8.1.2.2 Product Benchmarking
8.1.3 Corium International, Inc.
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Johnson and Johnson
8.1.4.1 Company Overview
8.1.4.2 Product Benchmarking
8.1.5 Alkermes plc
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Strategic Initiatives
8.1.6 Pfizer, Inc.
8.1.6.1 Company Overview
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.6.4 Strategic Initiatives
8.1.7 Orbis Biosciences, Inc.
8.1.7.1 Company Overview
8.1.7.2 Product Benchmarking
8.1.8 Capsugel
8.1.8.1 Company Overview
8.1.8.2 Product Benchmarking
8.1.8.3 Strategic Initiatives
8.1.9 Merck and Co., Inc.
8.1.9.1 Company Overview
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.10 Aradigm Corporation
8.1.10.1 Company Overview
8.1.10.2 Financial Performance
8.1.10.3 Product Benchmarking
List of Tables
TABLE 1 Factors used in segment share estimation
TABLE 2 List of secondary data sources
TABLE 3 North America controlled release drug delivery market, by country, 2014 –2025 (USD Billion)
TABLE 4 North America controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 5 North America controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 6 North America controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 7 North America controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 8 North America controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 9 U.S. controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 10 U.S. controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 11 U.S. controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 12 U.S. controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 13 U.S. controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 14 Canada controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 15 Canada controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 16 Canada controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 17 Canada controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 18 Canada controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 19 Europe controlled release drug delivery market, by country, 2014 - 2025 (USD Billion)
TABLE 20 Europe controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 21 Europe controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 22 Europe controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 23 Europe controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 24 Europe controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 25 Germany controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 26 Germany controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 27 Germany controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 28 Germany controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 29 Germany controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 30 U.K. controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 31 U.K. controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 32 U.K. controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 33 U.K. controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 34 U.K. controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 35 France controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 36 France controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 37 France controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 38 France controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 39 France controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 40 Italy controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 41 Italy controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 42 Italy controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 43 Italy controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 44 Italy controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 45 Spain controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 46 Spain controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 47 Spain controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 48 Spain controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 49 Spain controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 50 Rest of Europe controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 51 Rest of Europe controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 52 Rest of Europe controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 53 Rest of Europe controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 54 Rest of Europe controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 55 Asia Pacific controlled release drug delivery market, by country, 2014 - 2025 (USD Billion)
TABLE 56 Asia Pacific controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 57 Asia Pacific controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 58 Asia Pacific controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 59 Asia Pacific controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 60 Asia Pacific controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 61 Japan controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 62 Japan controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 63 Japan controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 64 Japan controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 65 Japan controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 66 China controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 67 China controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 68 China controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 69 China controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 70 China controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 71 India controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 72 India controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 73 India controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 74 India controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 75 India controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 76 Rest of Asia Pacific controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 77 Rest of Asia Pacific controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 78 Rest of Asia Pacific controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 79 Rest of Asia Pacific controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 80 Rest of Asia Pacific controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 81 Latin America controlled release drug delivery market, by country, 2014 - 2025 (USD Billion)
TABLE 82 Latin America controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 83 Latin America controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 84 Latin America controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 85 Latin America controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 86 Latin America controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 87 Brazil controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 88 Brazil controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 89 Brazil controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 90 Brazil controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 91 Brazil controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 92 Mexico controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 93 Mexico controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 94 Mexico controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 95 Mexico controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 96 Mexico controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 97 Rest of Latin America controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 98 Rest of Latin America controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 99 Rest of Latin America controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 100 Rest of Latin America controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 101 Rest of Latin America controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 102 MEA controlled release drug delivery market, by country, 2014 - 2025 (USD Billion)
TABLE 103 MEA controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 104 MEA controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 105 MEA controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 106 MEA controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 107 MEA controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 108 South Africa controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 109 South Africa controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 110 South Africa controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 111 South Africa controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 112 South Africa controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 113 Saudi Arabia controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 114 Saudi Arabia controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 115 Saudi Arabia controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 116 Saudi Arabia controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 117 Saudi Arabia controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
TABLE 118 Rest of MEA controlled release drug delivery, by technology, 2014 - 2025 (USD Billion)
TABLE 119 Rest of MEA controlled release drug delivery, by release mechanism, 2014 - 2025 (USD Billion)
TABLE 120 Rest of MEA controlled release drug delivery, by activation modulated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 121 Rest of MEA controlled release drug delivery, by chemically activated drug delivery systems, 2014 - 2025 (USD Billion)
TABLE 122 Rest of MEA controlled release drug delivery, by application, 2014 - 2025 (USD Billion)
List of Figures
FIG. 1 Primary interviews, by sources
FIG. 2 Primary interviews, by region
FIG. 3 Market summary
FIG. 4 Market trends & outlook
FIG. 5 Market segmentation & scope
FIG. 6 Market driver relevance analysis (Current & future impact)
FIG. 7 Market restraint relevance analysis (Current & future impact)
FIG. 8 Key opportunities prioritized, by technology
FIG. 9 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 10 Porter’s Five Forces Analysis
FIG. 11 Company market position analysis, 2016
FIG. 12 Controlled release drug delivery market, technology outlook: Key takeaways
FIG. 13 Controlled release drug delivery market: Technology movement analysis
FIG. 14 Wurster technique market, 2014 - 2025 (USD Billion)
FIG. 15 Coacervation market, 2014 - 2025 (USD Billion)
FIG. 16 Micro encapsulation market, 2014 - 2025 (USD Billion)
FIG. 17 Implants market, 2014 - 2025 (USD Billion)
FIG. 18 Transdermal market, 2014 - 2025 (USD Billion)
FIG. 19 Targeted delivery market, 2014 - 2025 (USD Billion)
FIG. 20 Others market, 2014 - 2025 (USD Billion)
FIG. 21 Controlled release drug delivery market, release mechanism outlook: Key takeaways
FIG. 22 Controlled release drug delivery market: Release Mechanism movement analysis
FIG. 23 Polymer based drug delivery systems market, 2014 - 2025 (USD Billion)
FIG. 24 Micro reservoir partition controlled drug delivery market, 2014 - 2025 (USD Billion)
FIG. 25 Feedback regulated drug delivery systems market, 2014 - 2025 (USD Billion)
FIG. 26 Activation modulated drug delivery market, 2014 - 2025 (USD Billion)
FIG. 27 Chemically controlled drug delivery market, 2014 - 2025 (USD Billion)
FIG. 28 Controlled release drug delivery market, Application outlook: Key takeaways
FIG. 29 Controlled release drug delivery market: Application movement analysis
FIG. 30 Metered dose inhalers market, 2014 - 2025 (USD Billion)
FIG. 31 Homecare market, 2014 - 2025 (USD Billion)
FIG. 32 Transdermal and ocular patches market, 2014 - 2025 (USD Billion)
FIG. 33 Infusion pumps market, 2014 - 2025 (USD Billion)
FIG. 34 Oral controlled drug delivery market, 2014 - 2025 (USD Billion)
FIG. 35 Drug eluting stents market, 2014 - 2025 (USD Billion)
FIG. 36 Regional market place: Key takeaways
FIG. 37 Regional outlook, 2016 & 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report